(NYSE: ATR) Aptargroup's forecast annual revenue growth rate of 5.33% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 10.55%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.11%.
Aptargroup's revenue in 2026 is $3,777,181,000.On average, 10 Wall Street analysts forecast ATR's revenue for 2026 to be $256,038,206,095, with the lowest ATR revenue forecast at $246,381,245,845, and the highest ATR revenue forecast at $269,042,912,565. On average, 10 Wall Street analysts forecast ATR's revenue for 2027 to be $268,785,393,625, with the lowest ATR revenue forecast at $257,905,218,410, and the highest ATR revenue forecast at $282,240,758,240.
In 2028, ATR is forecast to generate $285,524,124,725 in revenue, with the lowest revenue forecast at $271,038,684,350 and the highest revenue forecast at $301,104,020,595.